WeVote
Log In

Bill

Bill

S 1582

An Act improving Hepatitis C screening

194th Legislature (2025-2026) Introduced by Mark Montigny

Massachusetts bill expands Hepatitis C screening to improve early detection and treatment access, requiring healthcare system implementation and addressing coverage financing.

Accompanied a study order, see S2931
0
WeVote Research Nonpartisan
Bill Summary · S 1582

Legislative bill overview

S 1582 aims to expand Hepatitis C screening protocols in Massachusetts, likely mandating or incentivizing broader testing across healthcare settings and populations. The bill has progressed through public health committee review and is currently under consideration by the Health Care Financing Committee, suggesting it may include funding or insurance coverage provisions.

Why is this important

Hepatitis C affects an estimated 2.4 million Americans, many undiagnosed. Early detection enables curative antiviral treatments that prevent liver disease progression, reducing long-term healthcare costs and mortality. Improved screening addresses persistent disparities in diagnosis and treatment access across different populations.

Potential points of contention

  • Cost and funding mechanism: Who bears screening expenses—taxpayers, insurers, or healthcare providers—and whether adequate funding is appropriated
  • Scope of screening requirements: Disagreement over whether screening should be universal, risk-based, or age-targeted, with implications for healthcare provider burden
  • Privacy and data handling: Concerns about Hepatitis C test result confidentiality and whether positive results trigger mandatory reporting or insurance implications

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.